Hypersensitivity and adverse immune reactions are important considerations in human and animal health risk assessment.
BRT Labs offers a range of testing services to evaluate the hypersensitivity potential associated with test compounds in early-stage drug development. Our hypersensitivity tests provide valuable information for assessing product safety by using state-of-the-art technology and assays that measure the product’s effects on the relevant immune system pathways. We offer testing strategies both in vitro and in vivo to understand the risks, mechanisms, and potential adverse outcomes.
